{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:29:13Z","timestamp":1786969753761,"version":"build-2736575974"},"reference-count":30,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Distinguishing parathyroid carcinoma from parathyroid adenoma remains a major diagnostic challenge because these tumors frequently share similar clinical, biochemical, radiological, and histopathological features. Accurate diagnosis is essential for appropriate surgical management, highlighting the need for reliable adjunctive biomarkers. This study evaluated the diagnostic value of tumor angiogenesis, quantified by microvessel density (MVD), for differentiating parathyroid carcinoma from parathyroid adenoma and its association with clinicopathological characteristics. Methods: This retrospective study included 50 patients with primary hyperparathyroidism who underwent surgery at a tertiary endocrine surgery center, including 10 parathyroid carcinomas and 40 parathyroid adenomas. Tumor angiogenesis was assessed by immunohistochemical staining, and MVD was quantified in vascular hot spots using standardized methods. Receiver operating characteristic (ROC) analysis evaluated the diagnostic performance of MVD, while correlations with clinicopathological parameters were analyzed. Results: Parathyroid carcinoma demonstrated significantly higher MVD than parathyroid adenoma (median 901.14 vs. 431.24; p &lt; 0.001). ROC analysis showed excellent diagnostic performance, with an area under the curve of 0.917. Higher MVD was positively associated with Ki-67 expression, preoperative parathyroid hormone and calcium levels, and tumor weight, indicating a close relationship between angiogenesis, tumor proliferation, biochemical disease severity, and tumor burden. No significant associations were observed with age or preoperative phosphate levels. Conclusions: Quantitative assessment of MVD is a promising adjunctive immunohistochemical biomarker for distinguishing parathyroid carcinoma from parathyroid adenoma. Incorporating MVD into conventional histopathological evaluation may improve diagnostic confidence, particularly in morphologically challenging cases. Larger multicenter studies are warranted to validate these findings and further establish the clinical utility of MVD.<\/jats:p>","DOI":"10.3390\/cancers18162650","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:01:26Z","timestamp":1786968086000},"page":"2650","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microvessel Density as an Adjunctive Immunohistochemical Parameter in the Differential Diagnosis of Parathyroid Carcinoma and Adenoma\u2014An Immunohistochemical Study"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3159-891X","authenticated-orcid":false,"given":"Zorka","family":"Ini\u0107","sequence":"first","affiliation":[{"name":"Clinic for Surgical Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, Dr Suboti\u0107a 8, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Tau\u0161anovi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Dr Suboti\u0107a 8, 11000 Belgrade, Serbia"},{"name":"Clinic for Endocrine Surgery, University Clinical Center of Serbia, Pasterova 2, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8062-1250","authenticated-orcid":false,"given":"Marko","family":"Buta","sequence":"additional","affiliation":[{"name":"Clinic for Surgical Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, Dr Suboti\u0107a 8, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2977-4037","authenticated-orcid":false,"given":"Zoran","family":"Kozomara","sequence":"additional","affiliation":[{"name":"Clinic for Surgical Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, Dr Suboti\u0107a 8, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1891-1677","authenticated-orcid":false,"given":"Ognjen","family":"\u017divkovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5768-6256","authenticated-orcid":false,"given":"Nikola","family":"Jefti\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Surgical Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Ga\u010di\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Surgical Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9686-7044","authenticated-orcid":false,"given":"Dobrica","family":"Stevi\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Surgical Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5392-5062","authenticated-orcid":false,"given":"An\u0111ela","family":"Mili\u0107evi\u0107","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3917-541X","authenticated-orcid":false,"given":"Milan","family":"\u017degarac","sequence":"additional","affiliation":[{"name":"Clinic for Surgical Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, Dr Suboti\u0107a 8, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e220287","DOI":"10.1530\/ERC-22-0287","article-title":"Diagnosis and management of parathyroid carcinoma: A state-of-the-art review","volume":"30","author":"Roser","year":"2023","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1210\/clinem\/dgad455","article-title":"Approach to the Patient with Parathyroid Carcinoma","volume":"109","author":"Cetani","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s13193-021-01343-3","article-title":"Parathyroid Carcinoma: A Review","volume":"13","author":"Sawhney","year":"2022","journal-title":"Indian J. Surg. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/jcem.86.2.7207","article-title":"Parathyroid Carcinoma","volume":"86","author":"Shane","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","article-title":"Overview of the 2022 WHO Classification of Parathyroid Tumors","volume":"33","author":"Erickson","year":"2022","journal-title":"Endocr. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1016\/j.surge.2021.01.011","article-title":"Parathyroid cancer: A systematic review of diagnostic biomarkers","volume":"19","author":"Davies","year":"2021","journal-title":"Surgeon"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.humpath.2020.07.008","article-title":"Pathology data set for reporting parathyroid carcinoma and atypical parathyroid neoplasm: Recommendations from the International Collaboration on Cancer Reporting","volume":"110","author":"Williams","year":"2021","journal-title":"Hum. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000001017","article-title":"Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features","volume":"43","author":"Gill","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/EJE-21-1044","article-title":"European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021)","volume":"186","author":"Bollerslev","year":"2022","journal-title":"Eur. J. Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor Angiogenesis: Therapeutic Implications","volume":"285","author":"Sherwood","year":"1971","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0076-6879(08)02814-0","article-title":"Chapter 14. Measuring intratumoral microvessel density","volume":"444","author":"Weidner","year":"2008","journal-title":"Methods Enzymol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00666038","article-title":"Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors","volume":"36","author":"Weidner","year":"1995","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1385\/EP:17:2:175","article-title":"Microvessel Density in Human Normal and Neoplastic Parathyroids","volume":"17","author":"Viacava","year":"2006","journal-title":"Endocr. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1210\/jc.2003-031651","article-title":"Angiogenesis and Lymphangiogenesis in Parathyroid Proliferative Lesions","volume":"89","author":"Buley","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.anndiagpath.2015.01.002","article-title":"Angiogenesis in primary hyperparathyroidism","volume":"19","author":"Segiet","year":"2015","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12022-016-9426-7","article-title":"Role of Histological Criteria and Immunohistochemical Markers in Predicting Risk of Malignancy in Parathyroid Neoplasms","volume":"27","author":"Kumari","year":"2016","journal-title":"Endocr. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s00268-014-2700-2","article-title":"Parafibromin, Galectin-3, PGP9.5, Ki67, and Cyclin D1: Using an Immunohistochemical Panel to Aid in the Diagnosis of Parathyroid Cancer","volume":"38","author":"Truran","year":"2014","journal-title":"World J. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"BSR20181778","DOI":"10.1042\/BSR20181778","article-title":"Diagnostic and prognostic implications of parafibromin immunohistochemistry in parathyroid carcinomaT","volume":"39","author":"Pyo","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/cen.14161","article-title":"Prognostic role of parafibromin staining and CDC73 mutation in patients with parathyroid carcinoma: A systematic review and meta-analysis based on individual patient data","volume":"92","author":"Zhu","year":"2020","journal-title":"Clin. Endocrinol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Uljanovs, R., Sinkarevs, S., Strumfs, B., Vidusa, L., Merkurjeva, K., and Strumfa, I. (2022). Immunohistochemical Profile of Parathyroid Tumours: A Comprehensive Review. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23136981"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12022-018-9527-6","article-title":"Immunohistochemistry in Diagnostic Parathyroid Pathology","volume":"29","author":"Erickson","year":"2018","journal-title":"Endocr. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"World Medical Association (2013). World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA, 310, 2191.","DOI":"10.1001\/jama.2013.281053"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Sier, V.Q., van der Vorst, J.R., Quax, P.H.A., de Vries, M.R., Zonoobi, E., Vahrmeijer, A.L., Dekkers, I.A., de Geus-Oei, L.-F., Smits, A.M., and Cai, W. (2021). Endoglin\/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094804"},{"key":"ref_25","first-page":"2283","article-title":"Endoglin (CD105): A review of its role in angiogenesis and tumor diagnosis, progression and therapy","volume":"31","author":"Nassiri","year":"2011","journal-title":"Anticancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.amjsurg.2010.09.025","article-title":"Incidence and prognosis of parathyroid gland carcinoma: A population-based study in The Netherlands estimating the preoperative diagnosis","volume":"202","author":"Schaapveld","year":"2011","journal-title":"Am. J. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1245\/ASO.2005.06.005","article-title":"Primary Hyperparathyroidism: Can Parathyroid Carcinoma Be Anticipated on Clinical and Biochemical Grounds? Report of Nine Cases and Review of the Literature","volume":"12","author":"Robert","year":"2005","journal-title":"Ann. Surg. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/path.6153","article-title":"Application of digital pathology-based advanced analytics of tumour microenvironment organisation to predict prognosis and therapeutic response","volume":"260","author":"Fu","year":"2023","journal-title":"J. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"19163","DOI":"10.18632\/oncotarget.4383","article-title":"Continuous representation of tumor microvessel density and detection of angiogenic hotspots in histological whole-slide images","volume":"6","author":"Kather","year":"2015","journal-title":"Oncotarget"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Timakova, A., Ananev, V., Fayzullin, A., Makarov, V., Ivanova, E., Shekhter, A., and Timashev, P. (2023). Artificial Intelligence Assists in the Detection of Blood Vessels in Whole Slide Images: Practical Benefits for Oncological Pathology. Biomolecules, 13.","DOI":"10.3390\/biom13091327"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/16\/2650\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:14:29Z","timestamp":1786968869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/16\/2650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":30,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["cancers18162650"],"URL":"https:\/\/doi.org\/10.3390\/cancers18162650","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]}}}